132 related articles for article (PubMed ID: 26850271)
1. Cyst aspiration or GnRH antagonist administration for ovarian cysts detected at the start of fresh in vitro fertilization cycles.
Pereira N; Amrane S; Hobeika E; Lekovich JP; Chung PH; Rosenwaks Z
Gynecol Endocrinol; 2016 Jul; 32(7):562-5. PubMed ID: 26850271
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone.
Guo YH; Lu N; Zhang Y; Su YC; Wang Y; Zhang YL; Sun YP
Contemp Clin Trials; 2012 Nov; 33(6):1206-10. PubMed ID: 22820320
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.
Qublan HS; Amarin Z; Tahat YA; Smadi AZ; Kilani M
Hum Reprod; 2006 Mar; 21(3):640-4. PubMed ID: 16253965
[TBL] [Abstract][Full Text] [Related]
4. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
5. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
7. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
8. Effect of length of controlled ovarian hyperstimulation using a gonadotropin-releasing hormone antagonist on in vitro fertilization pregnancy rates.
Royster GD; Retzloff MG; Robinson RD; King JA; Propst AM
J Reprod Med; 2012; 57(9-10):415-20. PubMed ID: 23091989
[TBL] [Abstract][Full Text] [Related]
9. GnRH antagonist pre-treatment: one centre's experience for IVF-ICSI cycle scheduling.
Viardot-Foucault V; Nadarajah S; Lye WK; Tan HH
Reprod Biomed Online; 2015 Apr; 30(4):366-72. PubMed ID: 25684093
[TBL] [Abstract][Full Text] [Related]
10. Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist.
Lv M; Yu J; Chen P; Xiao Q; Lou L; Luo Y; Yuan M; Xu Y; Feng Y; Bai M; Zhang Z; Li L
Front Endocrinol (Lausanne); 2022; 13():1037220. PubMed ID: 36277710
[TBL] [Abstract][Full Text] [Related]
11. Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles.
Reichman DE; Zakarin L; Chao K; Meyer L; Davis OK; Rosenwaks Z
Fertil Steril; 2014 Jul; 102(1):99-102. PubMed ID: 24882557
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
13. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?
Reichman DE; Chung P; Meyer L; Greenwood E; Davis O; Rosenwaks Z
Fertil Steril; 2013 Apr; 99(5):1277-82. PubMed ID: 23290740
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
Pu D; Wu J; Liu J
Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
[TBL] [Abstract][Full Text] [Related]
15. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
16. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
[TBL] [Abstract][Full Text] [Related]
17. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
18. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels.
Orvieto R; Nahum R; Meltzer S; Liberty G; Anteby EY; Zohav E
Gynecol Endocrinol; 2013 Sep; 29(9):843-5. PubMed ID: 23802563
[TBL] [Abstract][Full Text] [Related]
19. The effect of ovarian cyst aspiration on IVF treatment with GnRH.
Firouzabadi RD; Sekhavat L; Javedani M
Arch Gynecol Obstet; 2010 Mar; 281(3):545-9. PubMed ID: 19657665
[TBL] [Abstract][Full Text] [Related]
20. [Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer].
Chen SL; Yin MN; Sun L; Li H; Chen X; Song HD; He JX; Zhu L; Xing FQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):588-90. PubMed ID: 17545062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
